Sign inJoin waitlistJoin the waitlist

Evie Hobbs

, Assistant Member · Providence Health & Services - Oregon

Credentials: · · · ·

History

Providence Health & Services - Oregon
Present

Medical Oncology
2019–2021
Internal Medicine
Oregon Health & Science University School of Medicine
2015–2018
David Geffen Sch of Med at UCLA
2011–2015

Research

Akt1 deletion prevents lung tumorigenesis by mutant K-ras
Oncogene · 2011 · 62 citations
Impact of TP53 mutations in Triple Negative Breast Cancer
npj Precision Oncology · 2022 · 34 citations
Development of the PARP inhibitor talazoparib for the treatment of advanced BRCA1 and BRCA2 mutated breast cancer
Review · Expert Opinion on Pharmacotherapy · 2021 · First of 3 authors · 29 citations

Richard Schilsky
3 papers
Bamidele Adesunloye
2 papers
Funda Meric-Bernstam
2 papers
JR
Jens Rueter
2 papers
Olatunji Alese
2 papers
PD
Phillip Dennis
2 papers
Ramya Thota
2 papers
TC
Timothy Cannon
2 papers
ZM
Zahi Mitri
2 papers
Alastair Thompson
1 paper
AZ
Alexandra Zimmer
1 paper
Alissa Marr
1 paper

Clinical trials

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
Principal investigator · Withdrawn · Early phase 1
OHSU Knight Cancer Institute
2023–2025
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Site PI · Recruiting · Phase 2
American Society of Clinical Oncology
2016–2028